InsiderFlow

Samit Hirawat

BMY

Samit Hirawat serves as EVP,Chief Med.Offr.,Drug Dev. at Bristol-Myers Squibb Company (BMY). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$402.3K

Total Sells

8 trades

$4.69M

Net Position

Net Seller

$4.29M

Companies Traded

1

BMY

Active Period

Mar 2021 – Apr 2025

11 total trades

Most Recent

Buy BMY

Apr 25, 2025 · $202.2K

Samit Hirawat's Insider Trading at Bristol-Myers Squibb Company (BMY)

Buys

3 · $402.3K

Sells

8 · $4.69M

Total Shares Bought

7,903

Total Shares Sold

73,642

BMY Price Chart
Loading chart...
DateTypeValue
Apr 25, 2025 Buy$202.2K
Mar 10, 2025 Sell$1.01M
Feb 19, 2025 Buy$100.0K
Nov 1, 2024 Buy$100.1K
Mar 10, 2024 Sell$734.2K
Jul 1, 2023 Sell$306.1K
Mar 10, 2023 Sell$1.47M
Jul 1, 2022 Sell$367.8K
Mar 10, 2022 Sell$356.1K
Jul 1, 2021 Sell$318.6K
Mar 10, 2021 Sell$120.5K